KS

Kamal Singh

Active Director Director DIN 09753304
DIN 09753304 First appointment Sep 2022 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2022
Shareholding value •••• Premium profile

About Kamal Singh

Data last updated:

Kamal Singh is a Director at Aayushveda Hospital Foundation (since 2022). The company operates in Healthcare. Aayushveda Hospital Foundation reported revenue of ₹40.4 Lakh (FY 2025).

DIN 09753304
Primary Designation Director
Industry Healthcare
First Appointment 30 Sep 2022
Oldest Company Age 4 yrs
Largest company Aayushveda Hospital Foundation · ₹40.4 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Aayushveda Hospital Foundation U85300RJ2022NPL084038
Director30 Sep 20222022₹40.4 Lakh (FY 2025)Active

Board colleagues of Kamal Singh

NameDINCompanyDesignation
Ruby09753303Aayushveda Hospital FoundationDirector

Directorship timeline

Open interactive timeline →
Aayushveda Hospital Foundation
Premium access

Shareholding and investment profile for Kamal Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kamal Singh

Kamal Singh currently holds 1 directorship: Aayushveda Hospital Foundation (Director, since 30 Sep 2022, revenue ₹40.4 Lakh (FY 2025)).

Kamal Singh was first appointed on 30 Sep 2022 as Director at Aayushveda Hospital Foundation.

The current boards of Kamal Singh's companies include Ruby (Aayushveda Hospital Foundation).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available